BookArunaloke Chakrabarti, editor.
Summary: This book discusses the unique epidemiology of fungal infections in Asia, illustrating that the situation in these countries is different from that in Western countries in terms of the causative species, natural history and management strategies. Asia, the world's largest continent and home to more than half the global population, has conditions that favor the growth of many fungi, including a number of unique species. Further, socio-economic conditions such as overcrowding, compromised health care facilities and lack of awareness add to the morbidity and mortality due to fungal diseases in this part of the world. Since the majority of Asian countries do not have good diagnostic mycology laboratories, antifungal management is often based on experience. The limited data from Asian countries suggest a very high incidence of fungal infections. This book addresses epidemiology of fungal infections in general and specific populations of Asia, fungal allergy, and diagnosis and management in resource-limited environments. The book is must read for busy clinicians, microbiologists and critical care providers.
Contents:
Intro; Distinctive Features of the Book; Contents; Editors and Contributors;
1: Introduction; References; Part I: Epidemiology in Asia;
2: Epidemiology of Superficial Fungal Infections in Asia; 2.1 Introduction; 2.2 Epidemiology of Dermatophytosis in Asia; 2.3 Epidemiology of Dermatophytes in India; 2.4 Epidemiology of Dermatophytes in China; 2.5 Epidemiology of Dermatophytes in Iran; 2.6 Epidemiology of Dermatophytes in Other Asian Countries; 2.7 Onychomycosis Due to Non-dermatophytic Molds; 2.8 Superficial Diseases Caused by Malassezia Species 2.8.1 Malassezia and Seborrheic Dermatitis/Dandruff2.8.2 Pityriasis Versicolor (PV); 2.8.3 Pityrosporum Folliculitis; 2.9 Tinea Nigra; 2.10 Piedra; 2.11 Fungal Keratitis; References;
3: Epidemiology of Endemic Mycoses in Asia; 3.1 Introduction; 3.2 Epidemiology of Histoplasmosis, Talaromycosis, and Blastomycosis in Asia; 3.3 Epidemiology of Sporotrichosis; References;
4: Epidemiology of Opportunist Fungal Infections in Asia; 4.1 Introduction; 4.1.1 Incidence/Prevalence; 4.1.2 Risk Factors/Underlying Illness; 4.1.2.1 Spectrum of Agents; 4.2 Conclusions; References Part II: Special Populatio
n5: Mycoses in Intensive Care Units; 5.1 Introduction; 5.2 Invasive Candidiasis (IC); 5.2.1 Invasive Mold Infection (IMI); 5.2.2 Pneumocystis jirovecii Pneumonia (PCP) [7]; 5.3 Conclusion; References;
6: Mycoses in AIDS; 6.1 Introduction; 6.1.1 Pneumocystis jirovecii Pneumonia; 6.1.2 Cryptococcosis; 6.1.3 Talaromycosis (Formerly Penicilliosis); 6.1.4 Histoplasmosis; 6.1.5 Mucosal Candidiasis; 6.1.6 Aspergillosis; References;
7: Mycoses in Neonates and Children; 7.1 Introduction; 7.2 Neonates; 7.2.1 Epidemiology 7.2.2 Clinical Presentation and Diagnosis7.2.3 Treatment [11]; 7.2.4 Prevention; 7.3 Children in the Critical Care Unit; 7.3.1 Epidemiology; 7.3.2 Risk Factors, Clinical Features and Diagnosis of IC; 7.3.3 Therapy; 7.3.4 Prevention; 7.4 Children on Cancer Chemotherapy/HSCT; 7.4.1 Epidemiology; 7.4.2 Diagnosis [22, 25]; 7.4.3 Treatment [22]; 7.4.4 Prevention/Prophylaxis [22, 26, 27]; 7.5 Children with Primary and Acquired Immunodeficiency; 7.6 Conclusions; References;
8: Mycoses in Transplant; 8.1 Fungal Infections in Solid Organ Transplant; 8.2 Epidemiology 8.3 Reported Studies on IFI In Renal Transplant Recipients8.4 Reported Studies on IFI in Liver Transplant Recipients; 8.5 Presentation of IFI in Solid Organ Transplant; 8.6 Evaluation of Patient with Possible IFI; 8.7 Diagnosis of IFI; 8.8 Treatment of IFI; 8.9 Prophylaxis Against IFI; 8.10 Fungal Infections in Stem Cell Transplant (SCT); 8.11 Presentation of IFI in HSCT; 8.12 Diagnosis of IFI; 8.13 Treatment of IFI; 8.14 Prophylaxis Against IFI; References;
9: Mycoses in Hematological Malignancies; 9.1 Introduction; 9.1.1 Magnitude of Problem; 9.2 IFD in AML; 9.3 IFD in ALL